Citadel Advisors’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-685,000
| Closed | -$7.79M | – | 7104 |
|
|
2023
Q4 | $7.79M | Buy |
685,000
+636,244
| +1,305% | +$7.23M | ﹤0.01% | 1372 |
|
|
2023
Q3 | $196K | Buy |
48,756
+48,119
| +7,554% | +$194K | ﹤0.01% | 4568 |
|
|
2023
Q2 | $4.53K | Buy |
+637
| New | +$4.53K | ﹤0.01% | 5470 |
|
|
2023
Q1 | – | Sell |
-1,446
| Closed | -$10.5K | – | 6862 |
|
|
2022
Q4 | $10.5K | Buy |
+1,446
| New | +$10.5K | ﹤0.01% | 5680 |
|
|
2022
Q3 | – | Sell |
-12,940
| Closed | -$247K | – | 7006 |
|
|
2022
Q2 | $247K | Buy |
+12,940
| New | +$247K | ﹤0.01% | 4805 |
|
|
2022
Q1 | – | Sell |
-1,760
| Closed | -$133K | – | 7429 |
|
|
2021
Q4 | $133K | Sell |
1,760
-4,533
| -72% | -$343K | ﹤0.01% | 5745 |
|
|
2021
Q3 | $497K | Buy |
6,293
+3,636
| +137% | +$287K | ﹤0.01% | 4538 |
|
|
2021
Q2 | $368K | Sell |
2,657
-28
| -1% | -$3.88K | ﹤0.01% | 5010 |
|
|
2021
Q1 | $562K | Buy |
2,685
+481
| +22% | +$101K | ﹤0.01% | 4475 |
|
|
2020
Q4 | $366K | Sell |
2,204
-2,814
| -56% | -$467K | ﹤0.01% | 4084 |
|
|
2020
Q3 | $853K | Buy |
5,018
+396
| +9% | +$67.3K | ﹤0.01% | 3064 |
|
|
2020
Q2 | $768K | Buy |
+4,622
| New | +$768K | ﹤0.01% | 3092 |
|